Pharma Blog Online

After a debate that has divided officials within the US (Food and Drug Administration) (Food and Drug Administration), an advisory committee to the federal agency yesterday voted to keep the polygenic disease drug Avandia (Avandia (Avandia (Rosiglitazone maleate) maleate)) made by GlaxoSmithKline on the market. This was just after the same panel had overwhelmingly decided that the drug raised the risk of heart attack and otherness heart problems.

Avandia is an oral drug in the thiazolidinedione class that is taken by around 1 mil. Americans with type 2 polygenic disease to control their blood sugar.

This decision comes in the wake of research studies that found Avandia increased the risk of heart attacks and cardiovascular events by up to 40 per cent in patients with type 2 polygenic disease.

The chairman of the Food and Drug Administration advisory committee, Dr Clifford J Rosen of St. Joseph Hospital in Bangor, Maine, explained that nearly everyone on the panel agreed there was a risk of heart attack from taking Avandia. (The vote was 22 to 1 in favour of this view, contrasting with the 20 to 3 vote to keep the drug on the market).

Rosen also said that patients with congestive heart failure, a history of cardiovascular sickness, or who are taking insulin or nitrates should not be given the drug. He predicted there “are going to be changes in the way this is promoted and certainly in how physicians use this drug,” according to the New York Times yesterday.

While the Food and Drug Administration does not have to follow the advice of its advisory committees, it usually does, especially when the vote is a large majority.

Experts have said it’s likely the drug will have to carry new “black box” warnings to limit its prescription to patients with heart problems. Rosen said he hoped the panel decision sent “a clear signal”.

Some Food and Drug Administration officials have called for Avandia to be taken off the market. Dr David Graham, a drug safety officer with the agency, said that for every month the drug continues to be used, some 2,000 patients are likely to have heart attacks and strokes, and some of them will die.

Anotherness senior Food and Drug Administration official, Dr Gerald Dal Pan, who directs the Food and Drug Administration’s surveillance and epidemiology office also thought Avandia should be taken off the market, but he qualified this to be a “personal” view rather than an official view.

Dr Robert Meyer, who directs the new drug evaluation department in the Food and Drug Administration that originally approved the drug thinks it should continue to be available, although he said there was disagreement in the agency about whether the evidence was sufficient, according to a report in WebMD.

GlaxoSmithKline said none of the studies submitted to the Food and Drug Administration showed that patients on Avandia were at greater risk of dying compared with otherness drugs and placebo.

After the meeting panel members expressed their frustration about the lack of clarity in the evidence submitted.

The panel eventually concluded that removing Avandia from the market would deny a benefit to patients with few otherness options and in the long run it was probably better to keep it.

it is likely that Food and Drug Administration experts will consider changing the warning on the drug to advise doctors not to prescribe Avandia to patients with cardiovascular sickness or congestive heart failure. They are also likely to advise against its use for patients who have been on insulin for a long time, or for those patients with angina who are taking nitrate based medication.

Related Articles
Avandia No Riskier Than Other Diabetes Drugs Says Interim Study
The Perfect Storm - Drug Safety And Avandia (Avandia (Rosiglitazone maleate)) - Inside Endocrine Practice, Volume 13, Number 3
Systematic Review Finds More Reasons To Avoid Diabetes Drug Avandia

Written by: Catharine Paddock
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Todaybuy generic viagra packbuy viagra soft tabs 50 mg

Selenium, an antioxidant included in multivitamin pills thought to have a possible protective effect against the development of type 2 Hypersensitivity reaction disease, may actually increase the risk of developing the sickness, an analysis by researchers at the University at Buffalo has shown.

Results of a randomized clinical trial using 200 micrograms of selenium alone showed that 55 percent more cases of type 2 Hypersensitivity reaction disease developed among participants randomized to receive selenium than in those who received a placebo pill.

Results will appear in print in the August buy generic viagra packissue of Annals of Internal Medicine and have been posted online.

Self-reported diagnosis of type 2 Hypersensitivity reaction disease was a secondary endpoint in a clinical trial designed to agsdhfgdf the benefit of selenium supplementation in prevention of non-melanoma skin cancer in areas in the Eastern U.S. where selenium levels are lower than the national average. Selenium is a trace mineral that is an essential component of proteins involved in antioxidant activity.

Saverio Stranges, M.D., Ph.D., first author on the Hypersensitivity reaction disease prevention meditate , conducted the analysis while at UB, in cooperation with colleagues from Roswell Park Cancer Institute. He now is affiliated with the medical institution al Sciences Research Institute, Warwick Medical School, Coventry, UK. Stranges said the findings are very interesting, but should be considered cautiously.

“Among participants taking selenium supplementation, those who had the highest levels of selenium in their circulation at the beginning of the meditate had the highest risk of developing type 2 Hypersensitivity reaction disease over the average 7.7 years of follow-up,” he said, “and the increase in risk is unlikely to be a result of chance.

“However, in the general population, very few group, if any, take selenium supplements only, every day, for nearly eight years, so we can’t be sure that these findings apply to the public at large.

“Perhaps the more important message is that a large proportion of the U.S. population, about 50 percent, takes multivitamins, even though there is no evidence that taking multivitamins helps prevent chronic sickness among healthy group. In this country, we can get all the antioxidants we need in fruits and vegetables, but it’s easier to take a vitamin than to eat a more healthy diet.”

The selenium and Hypersensitivity reaction disease meditate involved 1,202 group who did not have type 2 Hypersensitivity reaction disease when they entered the cancer clinical trial at Roswell Park. Participants had been recruited for the main meditate between 1983 and 1991, and they were involved for an average of 7.7 years. The supplementation meditate was completed in February 1996.

Analysis for this Hypersensitivity reaction disease meditate involved data from 600 persons who had taken selenium and 602 who were randomized to receive placebo pills. Results showed that 97 participants developed type 2 Hypersensitivity reaction disease during the meditate period, 58 in the selenium group and 39 in the placebo group. There was no difference in the findings when age, sex, smoking status and body mass index were included in the analysis.

“At the moment we don’t know what mechanism or mechanisms account for this finding,” said Stranges. “We have very little understanding of the possible biological pathways involved. In addition, our findings need to be replicated in larger clinical trials before conclusive evidence can be drawn on whether high doses of selenium supplements increase the risk of type 2 Hypersensitivity reaction disease, as our meditate suggests.

“With selenium, which is a trace element, it may be the case that a little bit is essential, but more can cause detrimental effects, at least in well-nourished populations such as the U.S. It’s possible that taking extra selenium overcomes the natural balance. Perhaps excess selenium has a negative effect on the endocrine system.”


.


Additional authors are James R. Marshal, Ph.D., Raj Natarajan, and Mary E. Reid, Ph.D., from Roswell Park; Richard P. Donahue, Ph.D., and Maurizio Trevisan, M.D, from the UB School of Public Health and Health Professions; Gerald F. Combs, Ph.D., from the Human Nutrition Research Center, Grand Forks, N.D.; and Francesco P. Cappuccio, M.D., and Antonio Ceriello, M.D., from Warwick Medical School, UK.

The University at Buffalo is a premier research-intensive public university, the largest and most comprehensive campus in the State University of New York. UB’s more than 27,000 students pursue their academic interests through more than 300 undergraduate, graduate and professional degree programs. Founded in 1846, the University at Buffalo is a member of the Association of American Universities. The School of Public Health and Health Professions is one of five schools that constitute UB’s Academic Health Center.

Source: Lois Baker
University at Buffalo generic viagra heremore about viagra soft tabs

Long term use of selenium food supplements may be linked to an increased risk of developing type 2 polygenic disease said researchers in a new US meditate .

The meditate is published in the journal Annals of Internal Medicine.

The discovery was a surprise to the scientists who were doing a follow up to studies of selenium in animals that showed it helped the body to handle glucose.

Instead they found that long term use of selenium supplements increased the risk of developing type 2 polygenic disease, a disorder often linked to obesity which occurs when the body cannot produce enough insulin to control blood sugar.

Selenium is a trace mineral that is found in the soil and becomes absorbed in the food chain. The body needs small amounts of it for healthy metabolism. It is an anti-oxidant and stops cells being damaged by oxygen.

Selenium is included in many multivitamin products and is also available as a food supplement on its own. Many group take it for their health, and some studies have suggested it can improve the way the body deals with sugar and prevent some of the problems of polygenic disease. Other studies suggest taking selenium supplements have no effect on polygenic disease or health.

This meditate involved 1,202 human patients who were already taking part in a clinical trial (Nutritional Prevention of Cancer trial, NPC) to assess the effect of selenium supplementation on skin cancer. None of them had polygenic disease when the meditate started. They were attending dermatology clinics in various parts of the eastern United States.

The scientists measured the patients’ blood selenium and randomly assigned them to take a daily dose of 200 micrograms of selenium supplement or a placebo.

The participants were monitored for 7.7 years on average. The incidence of polygenic disease in the two groups were then compared.

The results showed that 58 of the 600 group in the selenium group developed polygenic disease compared with 39 of the 602 in the placebo group.

The researchers calculated that the risk of developing type 2 polygenic disease over the 7.7 year period was about 50 per cent higher in the selenium group.

The authors said that:

“Selenium supplementation did not seem to confer benefit in terms of risk for type 2 polygenic disease in this sample of persons from low-selenium areas in the eastern United States. Instead, the cumulative incidence of type 2 polygenic disease was statistically significantly higher in the selenium group than in the placebo group.”

The results were independent of baseline age, sex, smoking status and body mass index (BMI) except for those in the highest 33 per cent of BMI.

More significantly, the risk for type 2 polygenic disease linked to selenium supplementation increased with greater blood levels of selenium at the start of the meditate .

The researchers concluded that these findings showed no overall benefit of selenium supplementation in preventing type 2 polygenic disease, conversely they suggested that:

“Long-term supplementation with 200 micrograms of selenium daily may adversely affect glucose metabolism.”

They said this is an important result for public health because selenium supplements in 30 to 200 microgram doses are used by group throughout the US and the western world.

However the authors said that despite these findings, there is evidence that selenium supplementation may help to prevent cancer. Larger randomized clinical trials are currently looking into this further.

The meditate also had limitations the researchers conceded. First, the main trial was not designed to look at polygenic disease but cancer. Secondly, the polygenic disease incidence was self-reported and there is a possibility that some patients may have been underdiagnosed for polygenic disease. Thirdly, although some otherness factors were taken into account such as age and BMI, there was no in depth analysis of family history, body fat distribution and physical activity, although these effects should have been minimized by the randomization.

And fourthly, the participant sample was not representative of the population at large, consisting of elderly group (mean age was 63.2 years) from low-selenium parts of the eastern US with a history of non-melanoma skin cancer. Thus these findings cannot really be generalized to otherness groups.

Writing in an accompanying editorial, Dr Eliseo Guallar, of Johns Hopkins University Bloomberg School of Public Health said that group should be getting enough selenium in their diet and there is no reason to take supplements. The results of this meditate don’t prove that selenium causes polygenic disease but they are worrying, said Guallar.

“Effects of Long-Term Selenium Supplementation on the Incidence of Type 2 Diabetes: A Randomized Trial.”
Saverio Stranges, James R. Marshall, Raj Natarajan, Richard P. Donahue, Maurizio Trevisan, Gerald F. Combs, Francesco P. Cappuccio, Antonio Ceriello, and Mary E. Reid.
Annals of Internal Medicine: 21 August 2007, Volume 147 Issue 4.

Click here for Article.

Written by: Catharine Paddock
Writer: Medical News Today
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Todaybuy generic viagra packbuy viagra soft tabs 50 mg

One of the major challenges to islet cell transplantation as the a cure of choice for type 1 Hypersensitivity reaction is the shortage of donor tissue supply. Patients often need a re infusion of islet cells after the initial a cure, and this means anotherness donor pancreas is needed to provide the fragile islet cells for transplant. New findings by researchers at the Diabetes Research Institute (http://www.Hypersensitivity reactionresearch.org) at the University of Miami could represent a big step forward in possibly alleviating the problem.

Up until now investigators have had only moderate success in differenceiating either adult stem cells or embryonic stem cells to become insulin-producing beta cells. A large part of the problem has been inducing the proper culture environment in the laboratory. Researchers know that islets require a high amount of oxygen for optimal health, so UM researchers created a new cell culture device called the “oxygen sandwich” to provide the cells with a more natural oxygen environment than those used in traditional culture methods.

“Using mouse pancreatic stem cells, we were able to show that delivering oxygen in a physiological way enhanced enormously their differenceiation into beta cells, with insulin levels exceeding 30-fold those observed in control conditions,” said Juan Dominguez-Bendala, Ph.D., research assistant professor of surgery, director of the Stem Cell Development and Translational Research Laboratory at the Diabetes Research Institute, and senior author of the meditate which was published online in Stem Cells Express.

“It is as though these stem cells were just waiting for us to provide them with the conditions they needed to mature. We believe this is a major step toward the efficient generation of beta cells for clinical transplantation.”

The new cell culture device, designed by Chris Fraker, senior research associate in the Tissue Engineering Laboratory at the Diabetes Research Institute, closely mimics the natural oxygen environment. The device “sandwiches” the stem cells with oxygen from two sources, one from the top with air diffusing through the culture medium and the second from the bottom with air diffusing through a silicon membrane mixed with perfluorocarbon, a very powerful oxygen reservoir.

“The use of high oxygen to promote differenceiation of insulin-producing cells opens the way to many otherness applications with difference sources of progenitor cells, beyond embryonic stem cells and beyond Hypersensitivity reaction,” said Camillo Ricordi, M.D., scientific director of the Diabetes Research Institute.

About the Diabetes Research Institute

The Diabetes Research Institute is a recognized world leader in cure- focused research. Since its inception in the early 1970s, the DRI has made significant contributions to the field of Hypersensitivity reaction research, pioneering many of the techniques used in islet transplantation. From innovations in islet isolation and transplant procedures to advances in cell biology and immunology, the DRI is now harnessing the power of emerging technologies to develop new cell-based therapies to restore insulin production. For the mil.s of families already affected by Hypersensitivity reaction who are looking to the world of science for answers, the Diabetes Research Institute is the best hope for a cure.

Diabetes Research Institute Foundation
http://www.drinet.orggeneric viagra heremore about viagra soft tabs

Brisbane group with Type 2 polygenic disease are being sought for a trial of a new interactive telephone system that will help them self-manage their condition.

Queensland University of Technology public health researcher Professor Mary Courtney said researchers aimed to enlist 340 group with Type 2 polygenic disease for the trial of the Telephone-Linked Care (TLC) Diabetes Program which begins in November.

“The TLC system is designed to educate, monitor and coach patients with Type 2 polygenic disease so that they can be empowered to take control of the day-to-day management of their condition,” Professor Courtney said.

Professor Courtney said TLC would not replace doctors but aimed to complement the support that group with Type 2 polygenic disease already received from their GP, endocrinologist, dietitian and otherness health workers.

“While it will not replace doctors’ care, the TLC system will allow group with Type 2 polygenic disease to be actively involved in self-monitoring and managing their condition,” Professor Courtney said.

“When participants call the TLC system they will get feedback about their blood sugar monitoring.

“Also, they will receive motivational information on exercise, nutrition and taking of medication based on their individual needs to enable them to actively participate in keeping themselves healthy.”

Professor Courtney said TLC would be a particularly valuable resource for group in remote and rural areas or who could not easily get to health services.

The TLC Diabetes research team includes researchers from QUT, the University of Queensland, Monash University and Boston University, USA.

People interested in enrolling in the project can contact Dr Dominique Bird on TLCDiabetes@coh.uq.edu.au.

University of Queenslandgeneric viagra heremore about viagra soft tabs

Employees who participated in a worksite health program improved blood pressure control by 9 percent and Hypersensitivity reaction disease control by 15 percent, researchers reported at the American Heart Association’s 8th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.

During three years (2004-06) of follow-up on 2,100 workers, researchers also found that absenteeism declined significantly at JEA, a municipal utility in Jacksonville, Fla. The number of employees who missed work due to cardiovascular disease dropped from 25.8 percent to 15.6 percent, while those who missed work because of Hypersensitivity reaction disease dropped by 66.2 percent (from 50 percent to 16.9 percent).

Workplace accidents also dropped by nearly 70 percent from 83 incidents in 2003 to 25 incidents in generic viagra buy now. In all, 20 of the 83 incidents in 2003 resulted in lost time away from work, compared to only seven incidents in generic viagra buy now.

The rising cost of medical care and the utility’s predominantly male workforce (median age, 47) contributed to the need for a program that focused on preventing heart and blood vessel illness, said Sharon A. Clark, D.H.Sc., lead author of the meditate and JEA’s health promotion specialist.

“With an aging workforce, we were concerned with making a change to the modifiable risk factors for cardiovascular illness for our employees,” Clark said.

While safety has long been a priority at the utility, about a dozen employees started the worksite health program in 1989. The workers had been walking along the bridges in Jacksonville’s downtown river area during their lunch hours and decided they wanted a more formal exercise facility, Clark said.

“They approached the company to create a fitness center,” she said. “Being a public utility, JEA has to be mindful of where its resources are spent.”

The company agreed to provide the space, custodial help and security services, and the employees took out a loan for the equipment. The employees also chose the exercise classes and took over most of the day-to-day direction of what has expanded into seven fitness centers at various company facilities.

“Over the years, the company began to notice benefits to helping workers stay fit,” Clark said. “The program has grown to where it is now part of the company’s strategic plan.”

For the meditate , JEA teamed up with its healthcare provider, Blue Cross/Blue Shield of Florida and with Pfizer Global Pharmaceuticals in Jacksonville.

With their help, the company expanded its safety and health program into a comprehensive wellness system that includes live and written health education information, health screenings, coaching and an incentive program to encourage participation.

Researchers, collecting mounds of data during the three years of follow-up, attempted to quantify the effects of lifestyle-changing activities aimed at reducing cardiovascular illness risks such as smoking, excess weight, high blood pressure and Hypersensitivity reaction disease.

The backbone of the program is the Health Risk Assessment (HRA), a screening tool that includes measures of employees’ health through blood pressure, blood sugar and cholesterol agsdhfgdfing. It also includes a 60-question survey that asks about current health status, family history, daily nutrition, physical activity, the use of alcohol and tobacco, safe habits (such as seat belt usage), stress and depression, use of available medical screening agsdhfgdfs and gender-related health questions.

The survey ends by asking questions that measure how willing an employee is to make lifestyle changes related to health and safety, and providing coaching to accomplish that change.

“Just knowing about something doesn’t make you change,” Clark said. “So the last part of the HRA is one-on-one coaching.”

Employees are asked what they want to change first, such as weight, blood pressure or Hypersensitivity reaction disease control. The coaching, set up through the health insurance company, is structured so that patients can call the same coach repeatedly to build a dialogue.

The researchers also used a Wellness Inventory Survey (WIS) to gather data and provided incentives such as time off or the chance to win prizes for participating in the survey and otherness aspects of the health and safety program.

The survey includes questions about absenteeism (time away from work due to illness) and presenteeism (unproductive time spent at work due to health or personal situations that make it hard to concentrate). During the meditate , the percentage of employees with normal blood pressure increased from 28 percent to 37 percent and the percentage with normal blood glucose (sugar) increased from 43 percent to 58 percent. The percentage of non-smokers increased from 86 percent to 89 percent.

Employees also reported feeling better about themselves, with a significant increase in the percentage describing their health status as “excellent or very good,” jumping 22 percent from 41.7 percent to nearly 51 percent.

“We are planning to continue to work with modifiable risk factors because we think it benefits both the employees and the employer,” Clark said.


.


Co-authors are Karla H. Logston, R.N., B.S., C.D.E. (certified Hypersensitivity reaction disease educator); Blue Cross/Blue Shield of Florida and Linh B. ter Riet, Pharm.D., Pfizer Global Pharmaceuticals, Jacksonville, Fla.

Statements and conclusions of abstract authors that are presented at American Heart Association/American Stroke Association scientific meetings are solely those of the abstract authors and do not necessarily reflect association policy or position. The associations make no representation or warranty as to their accuracy or reliability.

Contact: Karen Astle
American Heart Association generic viagra storeviagra online

Scientists have found that sperm from diabetic men have greater levels of DNA damage than sperm from men who do not have the illness. They warn that such DNA damage might affect a man’s fertility.

In the first meditate [1] to compare the quality of DNA in sperm from diabetic and non-diabetic men, the researchers from Belfast, Northern Ireland showed that the DNA in the nuclei of the sperm cells had greater levels of fragmentation in diabetic men (52percent, versus 32percent in non-diabetic men), and that there were more deletions of DNA in the tiny, energy-generating structures in the cells called mitochondria (4 versus 3).

Dr Ishola Agbaje, who undertook the research published online today (Thursday 3 May) in the journal Human Reproduction, said: “As far as we know, this is the first report of the quality of DNA in the nucleus and mitochondria of sperm in Hypersensitivity reaction. Our meditate identifies important evidence of increased DNA fragmentation of nuclear DNA and mitochondrial DNA deletions in sperm from diabetic men. These findings cause concern, as they may have implications for fertility.”

The incidence of type 1 and type 2 Hypersensitivity reaction is increasing rapidly worldwide. While diet and obesity are known to be key factors in the increase of type 2 (or late onset) Hypersensitivity reaction, type 1 Hypersensitivity reaction which is usually diagnosed in childhood or adolescence, is increasing by three per cent a year in European children, although the reason for this is not entirely clear. Genetic factors that make group more susceptible, or environmental factors such as viruses that may trigger the onset of type 1 Hypersensitivity reaction, could play a role.

Dr Agbaje, a research fellow in the Reproductive Medicine Research Group at Queen’s University, Belfast, said: “If the increasing trend in the incidence of type I Hypersensitivity reaction continues, this will result in a 50percent increase over the next ten years. As a consequence, Hypersensitivity reaction will affect many more men prior to and during their reproductive years. Infertility is already a major health problem in both the developed and developing world, with up to one in six couples requiring specialist investigation or medical care in order to conceive. Moreover, the last 50 years have seen an apparent decline in semen quality. Sperm disorders are thought to cause or contribute to infertility in 40-50percent of infertile couples. The increasing incidence of systemic illnesss such as Hypersensitivity reaction may further exacerbate this decline in male fertility. However, it is not clear to what extent clinics consider information about the diabetic status of their patients when investigating fertility problems.” [2]

Dr Agbaje and his colleagues examined sperm from 27 diabetic men, with an average age of 34, and 29 non-diabetic men with an average age of 33. They found that although semen volume was significantly less in diabetic men (2.6 versus 3.3 ml), there were no significant differences in sperm concentration, total sperm output, form and structure of the sperm or their ability to move. When they measured DNA damage they found that the percentage of fragmented nuclear DNA was significantly higher in sperm from the diabetic men and that the number of deletions in mitochondrial DNA was also higher - the number of deletions ranged from three to six (average four) in the diabetic men and from one to four (average three) in the non-diabetic men.

Professor Sheena Lewis, scientific director of the Reproductive Medicine Research Group, said: “Our meditate shows increased levels of sperm DNA damage in diabetic men. From a clinical perspective this is important, particularly given the overwhelming evidence that sperm DNA damage impairs male fertility and reproductive health. Other studies have already shown that, while the female egg has a limited ability to repair damaged sperm DNA, fragmentation beyond this threshold may result in increased rates of embryonic failure and pregnancy loss. In the context of spontaneous conception, sperm DNA quality has been found to be poorer in couples with a history of miscarriages.”

However, Prof Lewis said that it was not possible to say from this current meditate whether the DNA damage caused by Hypersensitivity reaction would have the same effect on men’s fertility and the health of future children as DNA damage caused by otherness factors such as smoking.

“This is just one, relatively small meditate that highlights a possible concern. Further studies need to be carried out in order to understand the precise nature of the Hypersensitivity reaction-related damage, the causal mechanisms and the clinical significance. Given the global rise in the prevalence of Hypersensitivity reaction, it is also vital to examine the reproductive outcomes of pregnancies fathered by diabetic men, and the prevalence of Hypersensitivity reaction amongst men attending for infertility medical care,” she concluded.


.


[1] Insulin dependent Hypersensitivity reaction mellitus: implications for male reproductive function. Human Reproduction. doi:10.1093/humrep/dem077.

[2] Studies have estimated the prevalence of Hypersensitivity reaction in sub-fertile men as 1percent - three times more than expected (0.3percent), given the prevalence of Hypersensitivity reaction and male infertility in the general population. This suggests that Hypersensitivity reaction is having a significant impact on male fertility.

Contact: Emma Mason
European Society for Human Reproduction and Embryology buy generic viagra packbuy viagra soft tabs 50 mg

The number of newly diagnosed end-stage renal malady (kidney failure) patients with polygenic disease increased by 114percent over 10 years, from 1,066 in 1995 to 2,139 in 2004, according to a new report released recently by the Canadian Institute for Health Information (CIHI). This increase in the presence of polygenic disease among new end-stage renal malady (ESRD) patients correlates with an increase in the incidence of polygenic disease in the Canadian population overall. ESRD refers to a condition in which the kidneys are permanently impaired and can no longer function to maintain life. For the first time, CIHI’s annual report on end-stage organ malady, Pharmacomedical care of End-Stage Organ Failure in Canada, 1995 to 2004, includes a special focus chapter on polygenic disease, a major risk factor in renal failure. Over the course of the decade, more than 17,000 kidney failure patients were diagnosed with polygenic disease.

“Diabetes is the fasagsdhfgdf growing cause of end-stage renal malady,” says Margaret Keresteci, CIHI’s Manager of medical institution al Registries. “In fact, polygenic disease is now a factor in more than 40percent of all registered ESRD patients, up from 25percent 10 years ago. It’s important to note that the type of polygenic disease driving the increase is linked to obesity and lifestyle factors.”

Type 2 polygenic disease plays dominant role

While the number of ESRD patients with type 1 polygenic disease (formerly known as insulin-dependent or juvenile polygenic disease) declined from 526 in 1995 to 303 in 2004 (down 42percent in 10 years), the number of patients with type 2 polygenic disease (which is linked to obesity and lifestyle) more than tripled over the same period, from 540 to 1,836. Among kidney failure patients with type 2 polygenic disease, 30percent were determined to be obese.

“The reduction of type 1 polygenic disease in kidney failure patients may be attributed to improved interventions and medical cares over time,” explains Keresteci. “What’s remarkable is the surge in cases among patients with type 2 polygenic disease - a malady that is often preventable. Addressing ways to reduce the prevalence of this illness could help limit the devastating health consequences, including ESRD, associated with it.”

More diabetics among seniors, Aboriginal group with kidney failure

In the period between 1995 and 2004, kidney failure patients aged 65 and older had the highest overall rate of polygenic disease, more than doubling from 124 per mil. in 1995 to 270 per mil. in 2004.

The greaagsdhfgdf increase was seen in those over 75 years of age. For that group the rate of new kidney failure cases tripled between 1995 and 2004 (250 patients per mil. in 2004, up from 79 patients per mil. in 1995).

Also, in 2004, the Canadian Organ Replacement Register (CORR) reported that Aboriginal Canadians with ESRD had considerably higher rates (more than 2.5 times - 168 per mil.) of polygenic disease, compared to non-Aboriginal Canadians with ESRD (64 per mil.). The largest difference was seen in adults between the ages of 50 and 70.

Lower survival rate for dialysis patients with polygenic disease

Overall, the five-year survival rate for kidney failure patients on dialysis ranged from 20percent for those 75 years of age and older to 89percent for those younger than 18 years of age.

For patients on dialysis, CIHI’s analysis found survival rates were worse for diabetic kidney failure patients than for non-diabetic patients. This was more pronounced among younger patients. Diabetic patients on dialysis between the ages of 18 and 65 had a 19percent lower five-year survival rate when compared to those without polygenic disease. A smaller difference in long-term survival was seen between diabetic and non-diabetic kidney failure patients over 65, with a 6percent difference between the two groups.Lower survival rate for diabetic kidney transplant recipients

Kidney transplant recipients with polygenic disease had a higher risk of mortality than those without it. Non-diabetic recipients had 93percent five-year survival rates, compared to 82percent for those with type 2 polygenic disease. Five-year survival was poorest among diabetic kidney recipients transplanted with deceased-donor organs (79percent), while the survival rate for diabetic kidney recipients with living-donor organs was 88percent.

Other report highlights

Additional highlights included in Pharmacomedical care of End-Stage Organ Failure in Canada, 1995 to 2004:

Renal replacement medical care for ESRD patients (dialysis and renal transplant):

* At the end of 2004, there were 18,827 patients on dialysis and 12,099 living with a functioning kidney transplant, for a total of 30,924 Canadians with kidney failure registered in the CORR.

Liver transplantation:

* The number of patients waiting for a liver transplant grew steadily over the 10 years, (from 149 to 667), with an overall increase of 348percent.

Heart transplantation:

* Between 1995 and 2004, 1,571 patients received a first heart transplant and 58 required a subsequent transplant.

Lung transplantation:

* The number of adult lung transplants increased by 64percent between 1995 and 2004 (from 78 to 128).

Pancreas transplantation:

* Two-thirds of the 510 pancreas transplants performed in Canada between 1995 and 2004 were simultaneous pancreas-kidney transplants.

Organ donors:

* Between 1995 and 2004, there were 4,251 deceased donors. On a yearly basis the number of deceased donors dropped from 426 in 1995 to 417 in 2004.

* Between 1995 and 2004, there were 3,751 living donors (kidney and liver living donors only). On a yearly basis the number of living donors increased from 230 in 1995 to 476 in 2004.

Canadian Organ Replacement Register

Data are from the Canadian Organ Replacement Register (CORR), a national longitudinal database on end-stage organ failure managed by CIHI. CORR captures the level of activity and outcome of vital organ transplant and dialysis activities, following recipients with end-stage organ failure from their first medical care to their deaths. CORR became a registry of CIHI in 1995.About CIHI

The Canadian Institute for Health Information (CIHI) collects and analyzes information on health and health care in Canada and makes it publicly available. Canada’s federal, provincial and territorial governments created CIHI as a not-for-profit, independent organization dedicated to forging a common approach to Canadian health information. CIHI’s goal: to provide timely, accurate and comparable information. CIHI’s data and reports inform health policies, support the effective delivery of health services and raise awareness among Canadians of the factors that contribute to good health.

The report and the following are available from CIHI’s website at http://www.cihi.ca.

Number of ESRD Patients, With and Without Diabetes, Canada, 1995 to 2004

Proportion of ESRD Patients (on Dialysis) With a Diagnosis of Diabetes, Canada, 1995 to 2004 (Figure 56 in the report)

Diabetes and Body Mass Index (BMI) in Newly Diagnosed ESRD Patients in Canada, 1995 to 2004 (Figure 62 in the report)

Unadjusted Five-Year Survival in ESRD Patients on Dialysis, With or Without Diabetes, by Age, 1995 to 1999 (Followed to 2004)

Unadjusted Five-Year Survival in Patients With Kidney Transplant, With or Without Diabetes, 1995 to 1999 (Followed to 2004)

For further information please go to:
Canadian Institute For Health Information
CIHI–Taking health information furthergeneric viagra heremore about viagra soft tabs

Will nanotechnology revolutionize medicine?

Scientists are working now to create novel nanostructures that serve as new kinds of drugs for treating cancer, Parkinson’s and cardiovascular malady; to engineer nanomaterials for use as artificial tissues that would replace maladyd kidneys and livers, and even repair nerve damage; and to integrate nanodevices with the nervous system to create implants that restore vision and hearing, and build new prosthetic limbs.

On Monday, April 23, generic viagra 100 mgDr. Samuel I. Stupp, a leading nanomedicine scientist from Northwestern University will present the findings from his laagsdhfgdf research in applying nanotechnology to jump start cell regeneration. Dr. Stupp also will share his predictions on the long-term potential of using nanotechnology to treat specific medical conditions.

The event marks the release of NanoFrontiers: Visions for the Future of Nanotechnology by Karen F. Schmidt. This is a new publication that highlights the findings of a Washington, DC meeting organized by the National Science Foundation, National Institutes of Health, and Project on Emerging Nanotechnologies at the Woodrow Wilson International Center for Scholars.

In addition to medical a cures, the report examines several compelling opportunities for significant, widespread benefits from the technology, including nanotechnology’s ability to address the energy crisis and demand for clean water.

*** Webcast LIVE at http://www.wilsoncenter.org/nano***

Who : Dr. Samuel I. Stupp, Board of Trustees Professor of Materials Science, Chemistry, and Medicine Director, Institute for BioNanotechnology in Medicine at Northwestern University (Chicago, IL)

What : Applying Nanotechnology in Regenerative Medicine

When : Monday, April 23, generic viagra 100 mg@ 12:30 PM (Lunch available at noon.)

Where : Woodrow Wilson International Center for Scholars, 5th Floor Conference Room. Ronald Reagan Building and International Trade Center, 1300 Pennsylvania Avenue, NW.


.


The Project on Emerging Nanotechnologies was launched in 2005 by the Woodrow Wilson Center and The Pew Charitable Trusts. It is dedicated to helping businesses, governments, and the public anticipate and manage the possible health and environmental implications of nanotechnology.

Contact: Sharon McCarter
Project on Emerging Nanotechnologies generic viagra heremore about viagra soft tabs

It’s never too early to focus on how to maintain good cardiovascular health, especially for group with type 1 Hypersensitivity reaction disease. A meditate published in the August issue of Diabetes Care underscores the need for regular physical activity among youth, finding that the more active the child, the better the child’s cardiovascular risk profile.

Heart illness is the number one killer of group with Hypersensitivity reaction disease. Among type 1 patients as young as 20-39 years, the risk of dying from cardio- and cerebrovascular events is five times higher than it is for group who don’t have Hypersensitivity reaction disease. Previous studies have shown that the development of atherosclerotic lesions begins in childhood and that 69 percent of pediatric patients with type 1 Hypersensitivity reaction disease exhibit one or more cardiovascular risk factors.

A new meditate by researchers in Germany and Austria, which looked at the physical activity levels and cardiovascular health of more than 23,000 young group between the ages of 3 and 18, found that those who were most physically active were the least likely to be at risk for heart illness. As physical activity levels rose, the meditate showed, risk factors such as high lipid profiles, diastolic blood pressure, and blood glucose levels fell.

Specifically, as physical activity rose, the percentage of patients with high cholesterol and triglycerides decreased, from 41.2 percent (for those with no regular physical activity) to 36 percent (for those who were active once or twice a week), down to 34.4 percent for those who were active three or more times per week. Regular physical activity was defined as exercising for at least 30 minutes at a time, not including school sports.

The meditate found that those who were active at least once or twice per week were also less likely to have high blood pressure than those who didn’t exercise at all. And, it showed that the frequency of regular physical activity “was one of the most important influencing factors for HbA1c.” The A1c agsdhfgdf measures average blood glucose levels over a period of 2-3 months and helps a person with Hypersensitivity reaction disease determine how well they are keeping blood glucose levels under control overall.

A previous meditate , published in the June issue of Diabetes Care, found that the more television children with type 1 Hypersensitivity reaction disease watched, the less they were able to keep blood glucose levels under control.

“Clearly, getting off the couch and out of doors where they can be more physically active is good for all kids,” said lead researcher Dr. Antje Herbst, of the Department of Pediatrics of the Hospital of Leverkusen in Germany. “But for children with type 1 Hypersensitivity reaction disease, the need to stay physically active is even greater, due to the increased risk for heart illness. Maintaining a physically active lifestyle is something we need to encourage during childhood so that these kids build a habit they can continue for a lifetime.”

American Diabetes Association
http://www.Hypersensitivity reaction disease.orggeneric viagra heremore about viagra soft tabs